相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients
Marios Politis et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats
Melissa M. Conti et al.
NEUROPHARMACOLOGY (2014)
SEROTONERGIC NERVE FIBERS IN L-DOPA-DERIVED DOPAMINE RELEASE AND DYSKINESIA
N. Nevalainen et al.
NEUROSCIENCE (2014)
Modulating mGluR5 and 5-HT1A/1B receptors to treat L-DOPA-induced dyskinesia: Effects of combined treatment and possible mechanisms of action
Hanna Iderberg et al.
EXPERIMENTAL NEUROLOGY (2013)
Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care
A. Antonini et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia
Erwan Bezard et al.
MOVEMENT DISORDERS (2013)
5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model
Elisabetta Tronci et al.
NEUROBIOLOGY OF DISEASE (2013)
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia
Erwan Bezard et al.
NEUROSCIENCE RESEARCH (2013)
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats
Christopher Bishop et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2012)
Serotonergic modulation of receptor occupancy in rats treated with l-DOPA after unilateral 6-OHDA lesioning
Adjmal Nahimi et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease
Eunju Shin et al.
NEUROBIOLOGY OF DISEASE (2012)
Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats
Kristin B. Dupre et al.
EXPERIMENTAL NEUROLOGY (2011)
CONTRIBUTION OF PRE-SYNAPTIC MECHANISMS TO L-DOPA-INDUCED DYSKINESIA
M. Carta et al.
NEUROSCIENCE (2011)
Maladaptive Plasticity of Serotonin Axon Terminals in Levodopa-Induced Dyskinesia
Daniella Rylander et al.
ANNALS OF NEUROLOGY (2010)
l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia
Hanna S. Lindgren et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease
Sylvia Navailles et al.
NEUROBIOLOGY OF DISEASE (2010)
Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA-induced dyskinesia in rats
Ayse Ulusoy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model
Ana Munoz et al.
EXPERIMENTAL NEUROLOGY (2009)
The Role of the Dorsal Raphe Nucleus in the Development, Expression, and Treatment of L-dopa-Induced Dyskinesia in Hemiparkinsonian Rats
Karen L. Eskow et al.
SYNAPSE (2009)
Combined 5-HTIA and 5-HTIB receptor agonists for the treatment of L-DOPA-induced dyskinesia
Ana Munoz et al.
BRAIN (2008)
Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat
Kristin B. Dupre et al.
NEUROPHARMACOLOGY (2008)
The partial 5-HT1A agonist buspirone reduces the expression and development of I-DOPA-induced dyskinesia in rats and improves I-DOPA efficacy
Karen L. Eskow et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease
Thomas Carlsson et al.
JOURNAL OF NEUROSCIENCE (2007)
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in Parkinsonian rats
Manolo Carta et al.
BRAIN (2007)
Sarizotan as a treatment for dyskinesias in Parkinson's disease:: A double-blind placebo-controlled trial
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2007)
Continuous Dopaminergic stimulation: Is it the answer to the motor complications of levodopa
John G. Nutt
MOVEMENT DISORDERS (2007)
Clinical correlates of levodopa-induced dopamine release in Parkinson disease - A PET study
N. Pavese et al.
NEUROLOGY (2006)
Development of dyskinesias in a 5-year trial of ropinirole and L-dopa
Olivier Rascol et al.
MOVEMENT DISORDERS (2006)
Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracelullar striatal dopamine
Wassilios Meissner et al.
NEUROBIOLOGY OF DISEASE (2006)
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID study)
CW Olanow et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand.: 1.: Neurochemical profile
GD Bartoszyk et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease:: implications for dyskinesias
R de la Fuente-Fernández et al.
BRAIN (2004)
Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models
F Bibbiani et al.
NEUROLOGY (2001)
分享论文
